These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16525565)

  • 41. Quantification of D-dimer levels in human saliva.
    Zhang X; Wan Y; Cooper-White J; Dimeski G; Atherton J; Punyadeera C
    Bioanalysis; 2013 Sep; 5(18):2249-56. PubMed ID: 24053240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.
    Olson JD
    Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of performance including influence by interfering substances of the Innovance D-dimer assay on the Sysmex coagulation analyzer.
    Park SJ; Chi HS; Chun SH; Jang S; Park CJ
    Ann Clin Lab Sci; 2011; 41(1):20-4. PubMed ID: 21325250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Standardization of FDP/D-dimer test].
    Fukutake K
    Rinsho Byori; 2011 Feb; Suppl 147():199-201. PubMed ID: 21761772
    [No Abstract]   [Full Text] [Related]  

  • 45. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Apr; 85(4):671-8. PubMed ID: 11341504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases].
    Kotschy M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):425-30. PubMed ID: 63429
    [No Abstract]   [Full Text] [Related]  

  • 47. Analytical comparison of AxSYM, HemosIL DD HS and Innovance D-dimer immunoassays with the Vidas D-dimer.
    Salvagno GL; Lippi G; Manzato F; Giavarina D; Montagnana M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):475-7. PubMed ID: 18503567
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
    Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
    Zhuang Q; Zeng Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral contraceptive and D-dimer level.
    Kittisupamongkol W
    Arch Dermatol; 2009 Feb; 145(2):210; author reply 210-1. PubMed ID: 19221279
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrin D-dimer and cardiovascular risk.
    Lowe GD
    Semin Vasc Med; 2005 Nov; 5(4):387-98. PubMed ID: 16302161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
    Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
    Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. D-dimer testing and venous thromboembolism: four view points.
    Dempfle CE
    J Thromb Haemost; 2005 Feb; 3(2):377-9. PubMed ID: 15670047
    [No Abstract]   [Full Text] [Related]  

  • 55. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
    Furusaki F; Sudo T; Tsutsui S
    Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical and prognostic significance of coagulation assays in lung cancer.
    Tas F; Kilic L; Serilmez M; Keskin S; Sen F; Duranyildiz D
    Respir Med; 2013 Mar; 107(3):451-7. PubMed ID: 23200643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
    Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Simultaneous quantification of soluble fibrin and D-dimer in blood plasma for the assessment of the threat of thrombosis].
    Lugovskii EV; Kolesnikova IN; Platonova TN; Lugovskaia NE; Litvinova LM; Kostiuchenko EP; Chernyshenko TM; Ganova LA; Spivak NIa; Komisarenko SV
    Klin Med (Mosk); 2013; 91(11):38-44. PubMed ID: 25696964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of antibody and fluorophore-derivatized liposomes to heterogeneous immunoassays for d-dimer.
    Singh AK; Kilpatrick PK; Carbonell RG
    Biotechnol Prog; 1996; 12(2):272-80. PubMed ID: 8857195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.